NAFTA Needs Strong IP Protections for America’s Creators and Innovators
Morning Consult, April 11, 2018
Ottawa blocking access to innovative drugs, writes pharmaceutical policy researcher Nigel Rawson
The Spectator, January 19, 2018
OPINION: American bureaucrats think our progressive agenda will derail NAFTA
The Toronto Sun, December 23, 2017
Cheaper isn’t always better, and prescription drugs are no exception
The Hill Times, December 14, 2017
As Trump Renegotiates NAFTA, Intellectual Property Rights Should Top the Agenda
The Daily Signal, October 17, 2017
New NAFTA must protect American innovation and creativity — not punish it
The Hill, October 11, 2017